摘要
临床药师通过追踪1例乳腺纤维腺瘤患者术后16 d合并大隐静脉血栓患者的诊疗过程,查阅相关资料,分析病因和评估治疗,发现其中可能存在不适宜的处置,并提出相关干预措施。对患者的评估应当更加细致并延长其血栓风险的筛查时长,必要时进行易栓体质的排查,且需根据现有指南选择适当的药物进行足量足疗程抗凝预防,而一旦发生血栓时应当根据指南进行规范的诊治。临床药师需参与乳腺纤维腺瘤患者围手术期及出院后血栓预防,推动抗栓药物的合理使用,并对出院的患者进行回访,做好用药教育。
作者
范琳琳
陈诚
陈莲珍
FAN Lin-lin;CHEN Cheng;CHEN Lian-zhen(Department of Pharmacy,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100021,China;Department of Nursing,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100021,China)
出处
《临床药物治疗杂志》
2020年第6期82-84,共3页
Clinical Medication Journal
